Live price temporarily unavailable.
Akanda (AKAN) is a Health Care company. Latest news and coverage below.
| FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | — | $2.06K | $41.4K | $2.62M | $423.7K | $836.7K |
| Growth (year over year) | — | — | +1909.3% | +6223.0% | −83.8% | +97.5% |
| Gross profit | — | −$58.2K | −$1.59K | — | $59.3K | $208.4K |
| Gross margin | — | −2821.3% | −3.8% | — | 14.0% | 24.9% |
| Operating income | −$901.2K | −$1.67M | −$2.57M | −$20.2M | −$3.66M | −$4.38M |
| Operating margin | — | −80781.0% | −6203.4% | −770.2% | −863.6% | −523.8% |
| Net income | −$1.39M | −$2.30M | −$8.13M | −$11.7M | −$32.3M | −$4.10M |
| Net margin | — | −111569.9% | −19625.9% | −445.0% | −7617.7% | −489.6% |
| EPS (diluted) | −$1.10 | −$1.80 | −$5.00 | −$3.86 | −$573.11 | −$3.93 |
| Balance sheet | ||||||
| Cash and equivalents | $819.6K | $13.5K | $3.50M | $255.8K | $93.9K | $3.84M |
| Total assets | — | $4.27M | $8.05M | $39.0M | $8.84M | $7.91M |
| Total liabilities | — | $9.31M | $10.2M | $12.1M | $12.7M | $3.64M |
| Shareholders' equity | −$2.90M | −$5.03M | −$2.20M | $26.9M | −$3.83M | $4.28M |
| Cash flow | ||||||
| Operating cash flow | — | — | −$6.56M | −$11.5M | −$1.50M | −$3.98M |
| Capital expenditure | $670.3K | $439.1K | $576.5K | $310.9K | $1.50K | $2.10M |
| Free cash flow | — | — | −$7.13M | −$11.8M | −$1.50M | −$6.08M |
From Akanda's 20-F and 6-K filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →
No recent news mentioning Akanda in our feed yet.